These Numbers Could Change Investor Views For Lexicon Pharmaceuticals Inc (NASDAQ: LXRX)
Currently, there are 363.18M common shares owned by the public and among those 177.07M shares have been available to trade. The company’s stock has a 5-day price change of 10.93% and 95.62% over the past three months. LXRX shares are trading -5.06% year to date (YTD), with the 12-month market performance down to -63.86% lower. […]
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) Stock In Prove Me State
Lexicon Pharmaceuticals Inc (LXRX) concluded trading on Thursday at a closing price of $0.72, with 7.83 million shares of worth about $5.64 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -10.48% during that period and on Thursday the price saw a gain of […]
Lexicon Pharmaceuticals Inc (LXRX) Outlook Starting To Look Brighter?
Lexicon Pharmaceuticals Inc (LXRX) concluded trading on Wednesday at a closing price of $0.61, with 5.56 million shares of worth about $3.39 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -37.08% during that period and on May 21, 2025 the price saw a […]
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) Loses -71.92% From High. Why That Could Change?
Currently, there are 361.49M common shares owned by the public and among those 179.54M shares have been available to trade. The company’s stock has a 5-day price change of 19.65% and -28.11% over the past three months. LXRX shares are trading -6.84% year to date (YTD), with the 12-month market performance down to -57.27% lower. […]
Why Should You Put Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) On Your Portfolio?
Currently, there are 361.49M common shares owned by the public and among those 179.54M shares have been available to trade. The company’s stock has a 5-day price change of 20.28% and -19.13% over the past three months. LXRX shares are trading -13.68% year to date (YTD), with the 12-month market performance down to -60.65% lower. […]
Growing Through Challenges? – Lexicon Pharmaceuticals Inc (LXRX)
Currently, there are 244.93M common shares owned by the public and among those 238.68M shares have been available to trade. Insiders at the company have transacted a total of 56 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 47 of these insider trades were purchases, […]
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX): The Best-Of-Breed For Investing?
Currently, there are 244.93M common shares owned by the public and among those 238.79M shares have been available to trade. Insiders at the company have transacted a total of 56 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 47 of these insider trades were purchases, […]
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX): Analyst View Points To Future Growth
Lexicon Pharmaceuticals Inc (LXRX) concluded trading on Wednesday at a closing price of $2.15, with 4.03 million shares of worth about $8.66 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 18.13% during that period and on Wednesday February 7 the price saw a […]
Are Analysts Expecting A Better 2020 For Lexicon Pharmaceuticals Inc (LXRX)?
Lexicon Pharmaceuticals Inc (LXRX) concluded trading on Wednesday at a closing price of $1.87, with 4.94 million shares of worth about $9.23 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -3.61% during that period and on Wednesday, January 31 the price saw a […]
Look At Analyst Expectations For A Better Read On Lexicon Pharmaceuticals Inc (NASDAQ: LXRX)
BlackRock Fund Advisors recently announced the acquisition of new stake in Lexicon Pharmaceuticals Inc (NASDAQ:LXRX). The institutional investor has increased its shareholding in the Healthcare company by 4.54% to 5.98 million shares with purchase of 0.26 million shares. This fresh investment now brings its stake to 2.44% valued currently at $9.15 million. In addition, Millennium […]